Infectious diseases in early life in industrialized countries

Vaccine

Volumn 16, Issue 14-15, 1998, Pages 1355-1359

  Wright, Peter F ^a   Wright, Penelope F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bacterial; Neonatal; Viral

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; VACCINE;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CONFERENCE PAPER; DISEASE TRANSMISSION; HEALTH PROMOTION; HUMAN; INDUSTRIALIZATION; INFECTION CONTROL; MATERNAL CARE; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PATHOGENESIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; VIRUS INFECTION;

BACTERIAL INFECTIONS; DEVELOPED COUNTRIES; HUMANS; INFANT; INFANT, NEWBORN; VIRUS DISEASES;

EID: 0032147061     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00091-7     Document Type: Conference Paper

References (19)

1. 1 Freedman, R.M., Ingram, D.L. and Gross, I. et al. A half-century of neonatal sepsis at Yale: 1928-1978. American Journal of Diseases in Children 1981, 135, 141-144.
2. 2 Fleming, D.T., McQuillan, G.M. and Johnson, R.E. et al. Herpes simplex type 2 in the United States, 1976-1994. New England Journal of Medicine 1997, 337, 1105-1111.
3. 3 Scott, G.B., Buck, B.E., Leterman, J.G., Bloom, F.L. and Parks, W.P. Acquired immunodeficiency syndrome in infants. New England Journal of Medicine 1984, 310, 76-81.
4. 4 Charles, D. and Larsen, B. Streptococcal puerperal sepsis and obstetrical infections: a historical perspective. Reviews in Infectious Diseases 1986, 8, 411-422.
5. 5 Boyer, K.M. and Gotoff, S.P. Prevention of early-onset group B streptococcal disease with selective intra-partum cheomoprophylaxis. New England Journal of Medicine 1986, 314, 1665-1669.
6. 6 Committee on Infectious Diseases and Committee on Fetus and Newborn, Revised guidelines for prevention of neonatal group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics, 1997, 99, 489-496.
7. 7 Baker, C.J. Group B streptococcal infections. Clinics in Perinatology 1997, 24, 59-70
8. 8 Oudesluys-Murphy, A.M. Umbilical cord care and neonatal tetanus. Lancet 1989, 1, 843.
9. 9 Craig, A.S., Reed, G.W. and Mohon, R.T. et al. Neonatal tetanus in the United States: a sentinel event in the foreign-born. Pediatric Infectious Diseases Journal 1997, 16, 955-959.
10. 10 Peckham, C. and Gibb, D. Mother-to-child transmission of the human immunodeficiency virus. New England Journal of Medicine 1997, 337, 509-515.
11. 11 Conner, E.M., Sperling, R.S. and Gelber, R. et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine 1994, 331, 1173-1180.
12. 12 Kasper, D.L., Paoletti, L.C. and Wessels, M.R. Immune response to type 111 group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. Journal of Clinical Investigation 1996, 98, 2308-2314.
13. 13 Dagan, R., Melamed, R. and Muallem, M. et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. Journal of Infectious Diseases 1996, 174, 1271-1278.
14. 14 Robertson, S.E., Cutts, F.T., Samuel, R. and Diaz-Ortega, J.L. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Bulletin WHO 1997, 75, 69-80.
15. 15 Straus, S.E., Wald, A. and Kost, R.G. et al. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo controlled vaccine trial. Journal of Infectious Diseases 1997, 176, 1129-1134.
16. 16 Istas, A.S., Demmler, G.J. and Dobbins, J.G. Surveillance for congenital cytomegalovirus disease: a report from the national congenital cytomegalovirus registry. Clinical Infectious Diseases 1995, 20, 665-670.
17. 17 Harrison, C., Britt, W. and Chapman, N. et al. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV in the guinea pig model. Journal of Infectious Diseases 1995, 172, 1212-1220.
18. 18 Anderson, L.J., Parker, R.A. and Strikas, R.L. Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths in infants and young children. Journal of Infectious Diseases 1990, 161, 640-646.
19. 19 Brandt, C., Power, U.F. and Plotnicky-Gilquin, H. et al. Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na. Journal of Infectious Diseases 1997, 176, 884-891.